Completed PHASE4 INTERVENTIONAL 2-arm NCT03066089

Clinical Evaluation of Fenfuro (Fenugreek Seed Extract) in Type-2 Diabetic Subjects: an add-on Study

Open Labeled, Interventional, Two Armed, Single Centric Study to Assess the Efficacy of Fenfuro (Fenugreek Seed Extract) in Type-2 Diabetic Subjects: an add-on Study

Sponsor: Chemical Resources

Conditions Type 2 Diabetes Mellitus

Interventions Fenfuro

Updated 6 times since 2017 Last updated: Jan 29, 2018 Started: Dec 14, 2015 Primary completion: Oct 31, 2017 Completion: Oct 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03066089, this PHASE4 trial focuses on Type 2 Diabetes Mellitus and remains completed. Sponsored by Chemical Resources, it has been updated 6 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2018 — Jun 2018 [monthly]

Completed PHASE4

Status: Recruiting → Completed

▶ Show 1 earlier version

May 2017 — Feb 2018 [monthly]

Recruiting PHASE4

First recorded

Dec 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chemical Resources

Data source: Chemical Resources

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rajpura, India